| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $261.3M | +31.6% |
| Cost of Revenue | $183.4M | +10.8% |
| Gross Profit | $78.0M | +136.1% |
| R&D Expense | $48.0M | +6.4% |
| SG&A Expense | $54.2M | +10.0% |
| Operating Income | -$26.6M | +59.5% |
| Pre-tax Income | -$22.8M | +62.6% |
| Income Tax | $699K | +1019.7% |
| Net Income | -$23.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.7M | +49.9% |
| Accounts Receivable | $50.8M | +45.7% |
| Inventory | $45.4M | +11.3% |
| Current Assets | $243.2M | +25.3% |
| Total Assets | $315.2M | +16.6% |
| Current Liabilities | $64.2M | +87.5% |
| Total Liabilities | $88.5M | +64.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21.3M | +1004.2% |
| Capital Expenditures | $9.0M | +13.9% |
| Investing Cash Flow | -$8.8M | -152.6% |
| Financing Cash Flow | $20.1M | +1643.4% |
| Free Cash Flow | $12.3M | +219.5% |
| +61.4% |
| EPS (Basic) | -$0.47 | +63.0% |
| EPS (Diluted) | -$0.47 | +63.0% |
| Stockholders' Equity |
| $226.7M |
| +4.8% |